Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Copper | [2] Copper Copper; Nicotinamide | - | - | - | [4] 2 2, 169, 170, 171 |
| 2 | Droxidopa | [4] DOPS DOPS; Droxidopa; L-DOPS; Northera | [1] D01277
D01277
| [9] ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | [14] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [5] 5 5, 6, 17, 169, 170 |
| 3 | Histidine | [2] Histidine Histidine; L-Histidine | [1] D00032
D00032
| - | - | [3] 13 13, 169, 170 |